GNL Gut and Liver
  1. Seung In Seo, Tae Jun Kim, Yoon Jin Choi, Chang Seok Bang, Yong Kang Lee, Moon Won Lee, Su Youn Nam, Woon Geon Shin. Clinical Characteristics and Treatment Pathway of Patients Treated with Helicobacter pylori Infection-A Single Center Cohort Study Using Common Data Model. Korean J Helicobacter Up Gastrointest Res 2022;22:214
    https://doi.org/10.7704/kjhugr.2022.0010
  2. Yong Hwan Kwon. Evidence-based Therapy: A Rational Approach to Helicobacter pylori Eradication. Korean J Helicobacter Up Gastrointest Res 2023;23:81
    https://doi.org/10.7704/kjhugr.2023.0027
  3. Kyoungwon Jung, Sam Ryong Jee, Moon Won Lee, Myeongseok Koh, Su Jin Kim, Jin Lee, Moo In Park. Comparison of Helicobacter pylori eradication rates between 7 and 14 days of tailored therapy according to clarithromycin resistance test: A randomized, multicenter, non‐inferiority study. Helicobacter 2024;29
    https://doi.org/10.1111/hel.13084
  4. Adalucy Alvarez-Aldana, Paula Andrea Fernandez Uribe, Tatiana Mejía Valencia, Yina Marcela Guaca-Gonzalez, Jorge Javier Santacruz-Ibarra, Brenda Lucia Arturo-Arias, Luis Javier Castañeda-Chavez, Robinson Pacheco-López, Lina María Londoño-Giraldo, José Ignacio Moncayo-Ortiz, Eleanor A. Powell, Vinoj Gopalakrishnan. Antimicrobial susceptibility of clinical Helicobacter pylori isolates and its eradication by standard triple therapy: a study in west central region of Colombia . Microbiol Spectr 2024;12
    https://doi.org/10.1128/spectrum.00401-24
  5. Soo-Young Na, Byung-Wook Kim, Min Ji Kim, Younghee Choe, Joon Sung Kim. Effective Eradication Regimen and Duration According to the Clarithromycin Susceptibility of Helicobacter pylori Determined Using Dual Priming Oligonucleotide-Based Multiplex Polymerase Chain Reaction. Gut and Liver 2023;17:722
    https://doi.org/10.5009/gnl220256
  6. Caio Constantini Rosa, Jessé Rodrigues de Moraes. Tratamento Das Infecções Por Helicobacter Pylori: Revisão De Ensaios Clínicos. jmrr 2022;1:e021
    https://doi.org/10.37497/JMRReview.v1i1.21
  7. Kunfeng Yan, Xiaorong Dai, Zhenxing Li, Weiwei Rong, Lei Chen, Xinxin Diao. Clinical Study on the Eradication of Helicobacter pylori by Vonoprazan Combined with Amoxicillin for 10‐Day Dual Therapy. Clinical Pharm in Drug Dev 2024;13:240
    https://doi.org/10.1002/cpdd.1357
  8. Ferit ÇELİK, Ali ŞENKAYA. Evaluation of the efficacy of two different Helicobacter pylori eradication regimens at a secondary public health care center. 2023;6:32
    https://doi.org/10.56150/tjhsl.1246441
  9. Myung Jin Song, Byung Wook Jung, Chan Hyuk Park. Comprehensive Analysis of Factors Associated With Helicobacter pylori Eradication Therapy. Korean J Helicobacter Up Gastrointest Res 2024;24:157
    https://doi.org/10.7704/kjhugr.2023.0063
  10. Kyung Ho Song. Bismuth, An Indispensable Component of Helicobacter pylori Eradication Therapy. Korean J Helicobacter Up Gastrointest Res 2023;23:79
    https://doi.org/10.7704/kjhugr.2023.0028
  11. Chang Kyo Oh, Hyun Lim, Seung In Seo, Sang Pyo Lee, Chang Seok Bang, Woon Geon Shin, Jin Bae Kim, Hyun Joo Jang, Gwang Ho Baik. Efficacy comparison of 7- and 14-day P-CAB based bismuth-containing quadruple regimen with PPI based bismuth-containing quadruple regimen for Helicobacter pylori infection: rationale and design of an open-label, multicenter, randomized controlled trial. BMC Gastroenterol 2023;23
    https://doi.org/10.1186/s12876-023-03100-y
  12. Gihong Park, Bokyung Kim, Hyunsoo Chung, Sang Gyun Kim, Soo-Jeong Cho. Types of 23S Ribosomal RNA Point Mutations Affecting Helicobacter pylori Eradication Rates in Clarithromycin-Based Triple Therapy. Korean J Helicobacter Up Gastrointest Res 2023;23:268
    https://doi.org/10.7704/kjhugr.2023.0037
  13. Chien-Lin Chen, I-Ting Wu, Deng-Chyang Wu, Wei-Yi Lei, Feng-Woei Tsay, Seng-Kee Chuah, Kuan-Yang Chen, Jyh-Chin Yang, Yu-Hwa Liu, Chao-Hung Kuo, Sz-Iuan Shiu, Chang-Bih Shie, Kuan-Hua Lin, Chia-Long Lee, Ping-I Hsu. Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori Infection. Microorganisms 2023;12:6
    https://doi.org/10.3390/microorganisms12010006
  14. Xiaoyin Peng, Yumei Liang, Yan Liu, Juan Zhang, Yong Chen, Qi Zhang, Xiangchun Zeng, Li Huang. The Comparison of the Clinical Efficacy and Drug Tissue Distribution of Furazolidone and Tetracycline-quadruple Therapy in Helicobacter pylori Eradication. 2025;59:70
    https://doi.org/10.1097/MCG.0000000000002044
  15. Moon Won Lee, Gwang Ha Kim. Bismuth-Based Quadruple Therapy for Clarithromycin-Resistant Helicobacter pylori Infection: Effectiveness and Cost-Efficiency. Gut and Liver 2022;16:807
    https://doi.org/10.5009/gnl220414
  16. June Hwa Bae, Hyeong Ho Jo, Joong Goo Kwon, Eun Young Kim. Efficacy of 7-day Tailored Therapy for Helicobacter pylori Eradication based on Clarithromycin Resistance. Korean J Gastroenterol 2023;82:10
    https://doi.org/10.4166/kjg.2023.039
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd